These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

575 related items for PubMed ID: 12419084

  • 1. Flow resistance in carotid and middle cerebral arteries in postmenopausal women: a comparative study of tibolone and continuous combined hormone replacement therapy.
    Pan HA, Wang ST, Chen CH, Pai MC, Wu MH, Huang KE.
    Climacteric; 2002 Sep; 5(3):259-65. PubMed ID: 12419084
    [Abstract] [Full Text] [Related]

  • 2. Cognitive function variations in postmenopausal women treated with continuous, combined HRT or tibolone. A comparison.
    Pan HA, Wang ST, Pai MC, Chen CH, Wu MH, Huang KE.
    J Reprod Med; 2003 May; 48(5):375-80. PubMed ID: 12815913
    [Abstract] [Full Text] [Related]

  • 3. A randomized, open-label study of conjugated equine estrogens plus medroxyprogesterone acetate versus tibolone: effects on symptom control, bleeding pattern, lipid profile and tolerability.
    Baracat EC, Barbosa IC, Giordano MG, Haidar MA, Marinho RM, Menegocci JC, Morais KM, Tomaz G, Wehba S.
    Climacteric; 2002 Mar; 5(1):60-9. PubMed ID: 11974560
    [Abstract] [Full Text] [Related]

  • 4. Effects of different postmenopausal hormone therapy regimens on cerebral blood flow and cognitive functions.
    Guvenal T, Durna A, Erden O, Guvenal F, Cetin M, Cetin A.
    Adv Ther; 2009 Aug; 26(8):805-11. PubMed ID: 19672567
    [Abstract] [Full Text] [Related]

  • 5. Conjugated estrogen/progestagen versus tibolone hormone replacement therapy in postmenopausal women: Effects on carbohydrate metabolism and serum sex hormone-binding globulin.
    Odmark IS, Carlström K, Jonsson B, Jonasson AF.
    Maturitas; 2006 Jan 10; 53(1):89-96. PubMed ID: 15964160
    [Abstract] [Full Text] [Related]

  • 6. Effect on sexual life--a comparison between tibolone and continuous combined conjugated equine estrogens and medroxyprogesterone acetate.
    Uygur D, Yeşildaglar N, Erkaya S.
    Gynecol Endocrinol; 2005 Apr 10; 20(4):209-12. PubMed ID: 16019363
    [Abstract] [Full Text] [Related]

  • 7. Short-term effects of hormone therapy on serum C-reactive protein levels in postmenopausal women.
    Kiran H, Kiran G.
    Arch Gynecol Obstet; 2006 Apr 10; 274(1):9-12. PubMed ID: 16369811
    [Abstract] [Full Text] [Related]

  • 8. Effects of oral and transdermal hormone replacement therapy on internal carotid artery pulsatility indices in postmenopausal women. A prospective, randomized, comparative study.
    Sendağ F, Terek MC, Karadadaş N, Bilgin O.
    J Reprod Med; 2001 Nov 10; 46(11):962-8. PubMed ID: 11762152
    [Abstract] [Full Text] [Related]

  • 9. Effect of conjugated estrogen versus conjugated estrogen associated with medroxyprogesterone acetate in postmenopausal women on internal carotid artery pulsatility index: a randomized pilot study.
    Wender MC, Vigo F, Oliveira PP, Bittellbrun F, Furtado AP, Schvartzman L, Capp E, de Freitas FM.
    J Obstet Gynaecol Res; 2011 Jul 10; 37(7):815-8. PubMed ID: 21410828
    [Abstract] [Full Text] [Related]

  • 10. Effect of hormone replacement therapy and tibolone on serum leptin levels in postmenopausal women.
    Lambrinoudaki IV, Christodoulakos GE, Panoulis CP, Rizos DA, Dendrinos SG, Liakakos T, Augoulea AD, Creatsas GC.
    Maturitas; 2004 Jun 15; 48(2):107-13. PubMed ID: 15172084
    [Abstract] [Full Text] [Related]

  • 11. Effects of tibolone on blood flow resistance and intima-media thickness of the carotid arteries: effect of time since menopause.
    Somunkiran A, Yazici B, Demirci F, Erdogmus B, Ozdemir I.
    Climacteric; 2006 Feb 15; 9(1):59-65. PubMed ID: 16428126
    [Abstract] [Full Text] [Related]

  • 12. Effect of conjugated equine estrogen in combination with two different progestogens on the risk factors of coronary heart disease in postmenopausal Chinese women in Taiwan: a randomized one-year study.
    Chang TC, Lien YR, Chen M, Cheng SP, Chen RJ, Chow SN.
    Acta Obstet Gynecol Scand; 2004 Jul 15; 83(7):661-6. PubMed ID: 15225192
    [Abstract] [Full Text] [Related]

  • 13. Significant differential effects of hormone therapy or tibolone on markers of cardiovascular disease in postmenopausal women: a randomized, double-blind, placebo-controlled, crossover study.
    Koh KK, Ahn JY, Jin DK, Yoon BK, Kim HS, Kim DS, Kang WC, Han SH, Choi IS, Shin EK.
    Arterioscler Thromb Vasc Biol; 2003 Oct 01; 23(10):1889-94. PubMed ID: 12933531
    [Abstract] [Full Text] [Related]

  • 14. Effects of continuous combined conjugated estrogen/medroxyprogesterone acetate and 17beta-estadiol/norethisterone acetate on lipids and lipoproteins.
    Odmark IS, Bäckström T, Haeger M, Jonsson B, Bixo M.
    Maturitas; 2004 Jun 15; 48(2):137-46. PubMed ID: 15172088
    [Abstract] [Full Text] [Related]

  • 15. The effect of tibolone and continuous combined conjugated equine oestrogens plus medroxyprogesterone acetate on progression of carotid intima-media thickness: the Osteoporosis Prevention and Arterial effects of tiboLone (OPAL) study.
    Bots ML, Evans GW, Riley W, McBride KH, Paskett ED, Helmond FA, Grobbee DE, OPAL Investigators.
    Eur Heart J; 2006 Mar 15; 27(6):746-55. PubMed ID: 16415304
    [Abstract] [Full Text] [Related]

  • 16. Effect of hormone replacement therapy on lipoprotein(a) and lipid levels in postmenopausal women. Influence of various progestogens and duration of therapy.
    Kim CJ, Min YK, Ryu WS, Kwak JW, Ryoo UH.
    Arch Intern Med; 2006 Mar 15; 156(15):1693-700. PubMed ID: 8694668
    [Abstract] [Full Text] [Related]

  • 17. The effect of continuous combined conjugated equine estrogen plus medroxyprogesterone acetate and tibolone on cardiovascular metabolic risk factors.
    Skouby SO, Sidelmann JJ, Nilas L, Gram J, Jespersen J.
    Climacteric; 2008 Mar 15; 11(6):489-97. PubMed ID: 18991076
    [Abstract] [Full Text] [Related]

  • 18. The differential effect of estrogen, estrogen-progestin and tibolone on coagulation inhibitors in postmenopausal women.
    Keramaris NC, Christodoulakos GE, Lambrinoudaki IV, Dalamanga A, Alexandrou AP, Bramis J, Bastounis E, Creatsas GC.
    Climacteric; 2007 Oct 15; 10(5):400-7. PubMed ID: 17852143
    [Abstract] [Full Text] [Related]

  • 19. Serum androgen levels and insulin resistance in postmenopausal women: association with hormone therapy, tibolone and raloxifene.
    Christodoulakos G, Lambrinoudaki I, Panoulis C, Sioulas V, Rizos D, Caramalis G, Botsis D, Creatsas G.
    Maturitas; 2005 Apr 11; 50(4):321-30. PubMed ID: 15780533
    [Abstract] [Full Text] [Related]

  • 20. Two-year prospective and comparative study on the effects of tibolone on lipid pattern, behavior of apolipoproteins AI and B.
    Castelo-Branco C, Casals E, Figueras F, Sanjuan A, Vicente JJ, Balasch J, Vanrell JA.
    Menopause; 1999 Apr 11; 6(2):92-7. PubMed ID: 10374214
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.